Sequential Vaccinations in Prostate Cancer Patients

NCT00060528 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

32

Enrollment

NIH

Sponsor class

Conditions

Prostatic Neoplasms

Interventions

DRUG: Recombinant Fowlpox-GM-CSF
DRUG: Recombinant Fowlpox-PSA (L155)-TRICOM (PROSTVAC-F/TRICOM)
DRUG: Recombinant Vaccinia-PSA (L155)-TRICOM (PROSTVAC-V/TRICOM)
DRUG: Recombinant Human GM-CSF

Sponsor

National Cancer Institute (NCI)